AI-augmented evidence as the next core competence in rare disease drug development: from snapshots to 360-degree movies

Ning Lu

Open source

DOI
10.1016/j.drudis.2026.104795
Published
2026-09
Container
Drug Discovery Today
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.drudis.2026.104795,
  title = {AI-augmented evidence as the next core competence in rare disease drug development: from snapshots to 360-degree movies},
  author = {Ning Lu},
  year = {2026},
  journal = {Drug Discovery Today},
  doi = {10.1016/j.drudis.2026.104795},
  url = {https://doi.org/10.1016/j.drudis.2026.104795}
}

RIS

TY  - JOUR
TI  - AI-augmented evidence as the next core competence in rare disease drug development: from snapshots to 360-degree movies
AU  - Ning Lu
PY  - 2026
JO  - Drug Discovery Today
DO  - 10.1016/j.drudis.2026.104795
UR  - https://doi.org/10.1016/j.drudis.2026.104795
ER  - 

APA

Lu, N. (2026). AI-augmented evidence as the next core competence in rare disease drug development: from snapshots to 360-degree movies. Drug Discovery Today. https://doi.org/10.1016/j.drudis.2026.104795

Source records